Protective Effect of Irbesartan by Inhibiting ANGPTL2 Expression in Diabetic Kidney Disease

Abstract

Angiopoietin-like protein 2 (ANGPTL2) stimulates inflammation and is important in the pathogenesis of diabetic kidney disease (DKD). Irbesartan is helpful in reducing diabetes-induced renal damage. In this study, the effects of irbesartan on DKD and its renal protective role involving ANGPTL2 in DKD rats were examined. Wistar rats were divided into normal, DKD, and DKD + irbesartan groups. The DKD + irbesartan group was treated once daily for 8 weeks with 50 mg/kg irbesartan via intragastric gavage. The 24-h urinary albumin was determined each week, renal pathological changes were observed, and expression of ANGPTL2 and nuclear factor-kappa B (NF-κB) in rat renal tissue was assessed by immunohistochemistry. Mouse podocytes cultured in a high concentration of glucose were classified into four groups based on the irbesartan concentrations (0, 25, 50, and 75 ºg/mL). Expression of ANGPTL2 and phosphorylated IκB-α was assessed by Western blotting. The mRNA levels of ANGPTL2 and monocyte chemotactic protein 1 (MCP-1) were assessed by real-time polymerase chain reaction. The DKD rats displayed proteinuria, podocyte injury, and increased ANGPTL2 and NF-κB expression. All were relieved by irbesartan treatment. In podocytes cultured in elevated glucose, ANGPTL2 and phosphorylated IκB-α were overexpressed at the protein level, and ANGPTL2 and MCP-1 were highly expressed at the mRNA level. Irbesartan down-regulated ANGPTL2 and phosphorylated IκB-αexpression at the protein level and inhibited ANGPTL2 and MCP-1 expression at the mRNA level. The ameliorative effects of irbesartan against DKD involves podocyte protection and suppression of ANGPTL2.

Keywords

angiopoietin-like protein 2 (ANGPTL2) / diabetes / kidney / inflammation

References

[1] American Diabetes Association. Microvascular complications and foot care: Standards of medical care in diabetes. Diabetes Care, 2018, 41(suppl 1): s105-s108

[2] ChengX, NayyarS, WangM, et al.. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol Dial Transplant, 2013, 28(3): 724-732

[3] BakrisGL, WilliamsM, DworkinL, et al.. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis, 2000, 36(3): 646-661

[4] ZiyadehFN, WolfG. Pathogenesis of the podoeytopathy and proteinuria in diabetic glomerulopathy. Curt Diabetes Rev, 2008, 4(1): 39-45

[5] LuisRD, MartinezCA, GorrizJL, et al.. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes, 2012, 3(1): 7-18

[6] WuCC, SytwuHK, LinYF. Cytokines in diabetic nephropathy. Adv Clin Chem, 2012, 56: 55-74

[7] TabataM, KadomatsuT, FukuharaS, et al.. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab, 2009, 10(3): 178-188

[8] SunH, ZhengJM, ChenS, et al.. Enhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathy. Nephron Exp Nephrol, 2007, 105(4): e117-e123

[9] KadomatsuT, EndoM, MiyataK, et al.. Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends Endocrinol Metab, 2014, 25(5): 245-254

[10] GalkinaE, LeyK. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol, 2006, 17(2): 368-377

[11] ChowF, OzolsE, Nikolic-PatersonDJ, et al.. Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury. Kidney Int, 2004, 65(1): 116-128

[12] ParvingHH, LehnertH, Brochner-MortensenJ, et al.. Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med, 2001, 345(12): 870-878

[13] PengH, XingYF, YeZC, et al.. High glucose induces activation of the localrenin angiotensin system in glomerular endothelial cells. Mol Med Rep, 2014, 9(2): 450-456

[14] IharaG, KiyomotoH, KoboriH, et al.. Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin D blockade. J Hypertens, 2010, 28(11): 2289-2298

[15] EvansM, BainSC, HoganS, et al.. Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial. Nephrol Dial Transplant, 2012, 27(6): 2255-2263

[16] TunçdemirM, OztürkM. The effects of angiotensin- II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy. Acta Histochem, 2011, 113(8): 826-832

[17] BonnetF, CooperME, KawachiH, et al.. Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia, 2001, 44(7): 874-877

[18] HartnerA, CordasicN, KlankeB, et al.. Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress. Biochim Biophys Acta, 2014, 1842(4): 558-565

[19] ChangFC, LaiTS, ChiangCK, et al.. Angiopoietin-2 is associtated with albuminuria and microinflammation in chronic kidney disease. PLoS One, 2013, 8(3): e54668

[20] UsuiT, NinomiyaT, NagataM, et al.. Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study. Circ J, 2013, 77(9): 2311-2317

[21] IshiiT, FuruyaF, TakahashiK, et al.. Angiopoietin-Like Protein 2 Promotes the Progression of Diabetic Kidney Disease. J Clin Endocrinol Metal, 2019, 104(1): 172-180

[22] ZhengJM, LiuZH, ZhangMC, et al.. Angiopoietin-like protein 2 is specifically expressed in the renal tissues of diabetic nephropathy db/db mice. Yixue Yanjiusheng Xuebao (Chinese), 2009, 22(9): 912-915

[23] YangS, ZhangJ, WangS, et al.. Knockdown of Angiopoietin-Like Protein2 Ameliorates Diabetic Nephropathy by Inhibiting TLR4. Cell Physiol Biochem, 2017, 43(2): 685-696

[24] SchnabelE, AndersonJM, FarquharMG. The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. J Cell Biol, 1990, 111(3): 1255-1263

[25] SharmaK, RamachandraraoS, QiuG, et al.. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest, 2008, 118(5): 1645-1656

[26] ChenY, LiuP, ChenX, et al.. Effects of Different Doses of Irbesartan Combined With Spironolactone on Urinary Albumin Excretion Rate in Elderly Patients With Early Type 2 Diabetic Nephropathy. Am J Med Sci, 2018, 355(5): 418-424

[27] HirasawaM, TakuboK, OsadaH, et al.. Angiopoietin-like Protein 2 Is a Multistep Regulator of Inflammatory Neovascularization in a Murine Model of Age-related Macular Degeneration. J Biol Chem, 2016, 291(14): 7373-7385

[28] SugimotoK, NakamuraT, TokunagaT, et al.. Angiopoietin-Like Protein 2 Induces Synovial Inflammation in the Facet Joint Leading to Degenerative Changes via Interleukin-6 Secretion. Asian Spine J, 2019, 13(3): 368-376